CMS Takes Action to Protect Integrity of Covid-19 Testing
The agency has issued cease-and-desist letters to laboratories conducting covid-19 testing without appropriate certification.
Read MorePosted by Melanie Hamilton-Basich | Oct 9, 2020 | Covid 19, Standards |
The agency has issued cease-and-desist letters to laboratories conducting covid-19 testing without appropriate certification.
Read MorePosted by Laurie Bonner | Oct 9, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The assay detects antibodies that recognize the receptor binding domain of the spike protein which the SARS-CoV-2 virus uses to enter the human host cells.
Read MorePosted by Laurie Bonner | Oct 9, 2020 | Covid 19, Lab Management |
New code additions and editorial revisions for reporting medical services were sparked by the public health response to the covid-19 pandemic.
Read MorePosted by Melanie Hamilton-Basich | Oct 8, 2020 | Covid 19, Immunoassay |
Inflammatix, Burlingame, Calif, a pioneering molecular diagnostics company, announced that the...
Read MorePosted by Laurie Bonner | Oct 8, 2020 | Covid 19, Molecular Diagnostics |
The RP2 Panel provides results in less than 2 hours for more than 20 viruses and bacteria that cause common respiratory infections with similar symptoms, including covid-19, flu, bronchitis and the common cold.
Read More